Subsequently, loss or reduction of Dab2 expression was found in other cancer types including rat mammary tumors[8], breast cancer[9,10], colon cancer[11], esophageal cancer[12], urothelial carcinomas[13], prostate cancer[14], head and neck cancer[15], and nasopharyngeal carcinomas[16]. This evidence concerns the gene DAB2 and breast cancer.